Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 4Lymphoid 4Breast 2Thoracic 1Sarcoma 1Other hematologic neoplasm 1NET 1Gastrointestinal 1Endocrine 1Classical hematology 1

Conditions

Leukemia 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma 7Leukemia, Lymphocytic, Chronic, B-Cell 7Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Burkitt Lymphoma 5Lymphoma, Mantle-Cell 4Leukemia, Myeloid, Acute 4Waldenstrom Macroglobulinemia 3Hematologic Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neutropenia 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Prolymphocytic 2Neoplasms 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Bronchiolitis Obliterans Syndrome 1Blast Crisis 1

Interventions

venetoclax 27Cyclophosphamide 18Azacitidine 13fludarabine 12ibrutinib 10Busulfan 10fludarabine phosphate 9Rituximab 8Mycophenolic Acid 8Methotrexate 8Cytarabine 8Whole-Body Irradiation 7Peripheral Blood Stem Cell Transplantation 7Clofarabine 7Therapeutics 6Melphalan 6Antilymphocyte Serum 6obinutuzumab 5Tacrolimus 5Surveys and Questionnaires 5Stem Cell Transplantation 5Mesna 5Exercise 5Cyclosporine 5vosaroxin 4trametinib 4thymoglobulin 4ruxolitinib 4ponatinib 4Trimethoprim, Sulfamethoxazole Drug Combination 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × pegfilgrastim × Other hematologic neoplasm × Clear all
NCT00410696 2013-07-01

Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy

Istituto Clinico Humanitas

Phase 2 Completed
80 enrolled
Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡